Related Experiment Video
Updated: Sep 12, 2025

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Emerging Therapeutic Strategies for Renal Ischemia-Reperfusion Injury in Kidney Transplantation: Progress and
Sohail Khan1, Dayanna Zuluaga1, Lloyd E Ratner2
1Department of Primary Care, Touro College of Osteopathic Medicine, Middletown, New York, USA.
Introduction:
Ischemia-reperfusion injury (IRI) contributes to delayed graft function (DGF) and long-term allograft loss in kidney transplantation (KTx). Despite decades of investigation, no pharmacologic strategy has achieved clinical translation. This systematic review evaluates investigational therapies for renal IRI (RIRI) reported since 2000.
Methods:
Following the PRISMA 2020 guidelines, a systematic search of PubMed, ClinicalTrials.gov, and the European Union Clinical Trials Register (EUCTR) was conducted for articles published between January 1, 2000, and March 31, 2025. Eligible records included preclinical and clinical investigations evaluating pharmacologic interventions for RIRI in KTx. Narrative reviews, pediatric-only, in silico-only, and in vitro-only records were excluded. A total of 76 full-text reports were assessed for eligibility, with 43 meeting the inclusion criteria. Meta-analysis was not performed due to heterogeneity. Included reports were synthesized by the mechanism of action, developmental stage, and translational status. Risk of bias was qualitatively assessed. This review was not prospectively registered, no formal protocol was prepared, and no external funding was received.
Results:
Legacy agents, Diannexin, YSPSL, and I5NP demonstrated initial promise but failed to achieve late-phase clinical efficacy. More recent agents, particularly alkaline phosphatase, complement-targeting biologics, and mesenchymal stem cell (MSC)-derived exosomes, offer mechanistically diverse strategies to attenuate RIRI, though most remain in early development.
Conclusion:
Most available data remain preclinical and are limited by inconsistent outcome measures and translational bottlenecks. Future efforts should prioritize harmonized animal models, biomarker-defined endpoints, and strategic investment in promising candidates to integrate them into kidney transplant care.
Insights
Investigational therapies for kidney transplant ischemia-reperfusion injury (IRI) show promise, but most remain preclinical. Future research needs standardized models and biomarkers to advance treatments for delayed graft function.
Area of Science:
- Nephrology
- Transplantation Immunology
- Pharmacology
Background:
- Ischemia-reperfusion injury (IRI) is a major cause of delayed graft function and long-term kidney transplant loss.
- No pharmacological strategy has successfully translated into clinical practice for renal IRI (RIRI).
Purpose of the Study:
- To systematically review investigational pharmacologic therapies for RIRI in kidney transplantation (KTx) reported since 2000.
Main Methods:
- Systematic search of PubMed, ClinicalTrials.gov, and EUCTR (2000-2025).
- Inclusion of preclinical and clinical studies on pharmacologic RIRI interventions in KTx.
- Exclusion of narrative reviews, pediatric-only, in silico-only, and in vitro-only studies.
- Synthesis of 43 included reports by mechanism of action, developmental stage, and translational status.
Main Results:
- Legacy agents (Diannexin, YSPSL, I5NP) failed late-phase clinical trials.
- Emerging therapies include alkaline phosphatase, complement inhibitors, and MSC-derived exosomes, mostly in early development.
- Most data are preclinical, with inconsistent outcome measures and translational challenges.
Conclusions:
- Significant translational bottlenecks and limited preclinical data hinder clinical application.
- Future research should focus on harmonized animal models and biomarker-defined endpoints.
- Strategic investment is needed to advance promising RIRI therapies for kidney transplant recipients.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

